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Abstract:  Sustained  high  concentration  of  glucose  has  been  verified  toxic  to  β-cells. 
Glucose augments Ca
2+-stimulated insulin release in pancreatic β-cells, but chronic high 
concentration of glucose could induce a sustained level of Ca
2+ in β-cells, which leads to cell 
apoptosis.  However,  the  mechanism  of  high  glucose-induced  β-cell  apoptosis  remains 
unclear. In this study, we use a calcium channel blocker, nifedipine, to investigate whether 
the inhibition of intracellular Ca
2+ concentration could protect β-cells from chronic high 
glucose-induced  apoptosis.  It  was  found  that  in  a  concentration  of  33.3  mM,  chronic 
stimulation of glucose could induce INS-1 β-cells apoptosis at least through the endoplasmic 
reticulum stress pathway and 10 µM nifedipine inhibited Ca
2+ release to protect β-cells from 
high glucose-induced endoplasmic reticulum stress and apoptosis. These results indicated 
that inhibition of Ca
2+ over-accumulation might provide benefit to attenuate islet  β-cell 
decompensation in a high glucose environment. 
Keyword: nifedipine; Ca
2+ homeostasis; β-cell; endoplasmic reticulum stress; apoptosis; 
high glucose 
 
OPEN ACCESS Int. J. Mol. Sci. 2011, 12  7570 
 
1. Introduction 
Type 2 diabetes (T2D) is characterized by hyperglycemia and insulin resistance [1,2] and increased 
level of blood glucose concentration has been proposed to induce β-cell loss in T2D [2–4]. Moreover, 
studies  in  cultured  β-cell  and  isolated  islets  have  described  that  long-term  exposure  to  a  high 
concentration  of  glucose  can  trigger  β-cell  apoptosis  [5–7].  In  the  process,  cytochrome  c  release, 
caspase 3 activation might be the main cause of cell death [3,8]. However, the molecular and cellular 
mechanisms of high concentration glucose-induced β-cell apoptosis have not been well investigated. 
Some stress occurrence was involved in high glucose-induced β-cell dysfunction, including oxidation 
stress,  vasoactive  cytokines  release,  barrier  function  changes,  and  endoplasmic  reticulum  (ER) 
stress [9–11]. 
Apoptotic ER stress was demonstrated to be critical in high glucose-induced β-cell apoptosis [12,13]. 
In pancreatic β-cells, ER stress is induced by overloaded chaperons, increased misfolded proteins, ER 
Ca
2+ depletion and failure of newly synthesized protein folding [14,15]. Such conditions could activate 
the unfolded protein response (UPR) that inhibits new protein synthesis, increase folding capacity, and 
degrade misfolded proteins [16,17]. In this process, a signal pathway such as PKR-like kinase (PERK) 
was  activated.  PERK  phosphorylates  eukaryotic  translation  initiation  factor2α  (eIF2α),  leads  to 
inhibition  of  new  protein  translation  [9,14,18]  and  the  proapoptotic  transcription  factor,  C/EBP 
homologous protein 10 (CHOP), which mediates the lethal effect of PERK signaling, is ubiquitously 
expressed at a very low level but robustly expressed under ER stress condition [19]. Prolonged ER stress 
leads to cell apoptosis, in which UPR is not sufficient to deal with accumulated misfolded proteins [17,19]. 
Consistent Ca
2+ release from ER stores by calcium influx is the main cause to elicit ER stress to 
induce cell apoptosis by activating some apoptosis signals such as caspase-3, CHOP [20]. In β-cells, 
Ca
2+ is a key regulator not only in cell survival, but also in insulin release. Glucose could activate 
ATP-dependent potassium channel [21], which leads to membrane depolarization, and voltage-gated 
L-type Ca
2+-channels are activated to stimulate intracellular Ca
2+ release from ER stores, triggering 
insulin release [21,22]. In T2D, consistent hyperglycemia stimulates sustained elevation of intracellular 
concentration  of  Ca
2+  ([Ca
2+]i)  for  insulin  secretion,  which  activates  various  Ca
2+  signals-related 
apoptosis pathways, including ER stress [20,23,24]. Thus, inhibition of an elevated level of [Ca
2+]i 
might benefit T2D treatment. 
To investigate the potential role of Ca
2+ in high concentrations of glucose-induced INS-1 β-cell 
apoptosis, nifedipine was utilized for efficacy studies , as one of L-type Ca
2+-channel antagonists [25]. In 
this study, we confirmed that Ca
2+ influx is strongly involved in high glucose-related β-cell apoptosis via 
ER stress pathway, and nifedipine could protect INS-1 β-cells from high glucose-induced ER stress  
and apoptosis. 
2. Materials and Methods 
2.1. Reagents 
All general reagents for cell culture were purchased from GIBCO, USA. Nifedipine, hoschst 33342 
and DAPI were from Sigma-Aldrich, USA. The fluorescence dyes Fluo-4/AM were from Invitrogen, 
USA. Insulin ELISA kit were from Millipore. Rabbit anti-GAPDH, phosphor-eIF2α, eIF2α, caspase 3 Int. J. Mol. Sci. 2011, 12  7571 
 
and insulin antibodies were purchased from Cell signaling technology, rabbit anti-CHOP (GADD153) 
antibody  were  from  Santa  Cruz  Biotechnology.  Peroxidase-conjugated  Goat  anti-rabbit  IgG  was 
purchased from Jackson Immuno Research. 
2.2. Cell Culture 
Rat  insulinoma  cell  line  INS-1  was  obtained  from  American  type  culture  collection  (ATCC).   
INS-1 cells were cultured in RPMI-1640 medium containing 10% (vv-l) fetal bovine serum (FBS),   
5.5  mM  glucose,  10  mM  HEPES,  100  units/mL  penicillin,  100  µg/mL  streptomycin  and  50  µM 
β-mercaptoethanol at 37 °C and 5% CO2 condition. Before the co-treatment with glucose at different 
concentration and nifedipine, cells were precultured in low-glucose condition (5.5 mM) overnight. In 
each glucose concentration, cells were incubated with or without 10 µM nifedipine for indicated time. 
2.3. MTT Assay 
INS-1 cells were seeded in 96-well plates (10, 000 cells per well) and treated as described above. 
After  24  h  cultured,  cell  viability  was  determined  by  using  a  3-(4,5-dimethylthiazol-2-yl)-2, 
5-diphenyltetrazolium bromide (MTT) assay described previously [26]. The results were shown as 
relative optical density. 
2.4. Hoechst 33342 Staining 
Apoptotic cells are evaluated by Hoechst 33342 staining. The nuclear of cells are stained by Hoechst 
33342 and show blue fluorescence. Compared with normal cells, the nuclei of apoptotic cells have 
highly condensed chromatin which could be visualized by fluorescence microscopy. 
2.5. Tunel Staining 
Cells were cultured on coverglasses in 12-well plates. After 24 h treatment, the apoptotic cells were 
stained by tunel staining kit following its protocol, the apoptotic cells were stained by green fluorescence, 
and all cells were marked with blue fluorescence using DAPI. The apoptotic ratio was calculated as 
tunnel-positive cells divided by total cell number. 
2.6. Western Blot Analysis 
INS-1 cells were treated as described above, and then cells were lysed by protein extraction kit 
(Beyotime, CN) according to its protocol. Western blot was performed as previously described [27], the 
following  primary  antibodies  were  used:  phosphor-eIF2α  (dilutions  1:1000),  eIF2α  (1:1000),   
CHOP (1:200), caspase 3 (1:500), GAPDH (1:5000). 
2.7. Calcium Mobilization Assay 
Calcium  mobilization  assay  was  performed  as  described  in  [28].  In  acute  calcium  influx 
determination, cells were stimulated by 33.3 mM glucose for 1 min in the presence of 0, 1, 3, 10 µM 
nifedipine. For long-term experiment, after 6 or 24 h treatment, the medium was removed and cells were Int. J. Mol. Sci. 2011, 12  7572 
 
pretreated with medium without glucose for 1 h, then INS-1 cells were stimulated with 33.3 mM glucose 
to measure [Ca
2+]i. 
2.8. Insulin Staining and Glucose Stimulated Insulin Secretion (GSIS) Assay 
INS-1 cells were seeded into 96-well plates (30,000 cells per well). After the treatment, cells were 
fixed for 2 h in 4% paraformaldehyde and then incubated with insulin antibody as described [29], the 
insulin content in INS-1 cells was captured by fluorescence microscope. In the end of treatment, cells 
were washed twice with Krebs buffer (118 mM NaCl, 4.7 mM KCl, 1.2 mM KH2PO4, 1.2 mM MgSO4, 
4.2 mM NaHCO3, 2 mM CaCl2), then the cells were incubated with 100 µL Krebs buffer containing 2.5 
mM  glucose  for  30  min.  Subsequently, wells were washed twice again and incubated with 20 mM 
glucose Krebs buffer instead. After 1 h incubation, the supernatant from each well were collected, 
following,  the  concentration  of  insulin  was  measured  by  rat  insulin  ELISA  kit  according  to  the 
manufacturer’s instructions (Millipore). 
2.9. Statistical Analysis 
Data were expressed as the mean ± SD. Two-tailed t test was performed and a value of p < 0.05 was 
considered significant. 
3. Results 
3.1. Nifedipine Protects INS-1 Cells from High Glucose-Induced Apoptosis 
High concentration of glucose has been demonstrated to be toxic to cultured β-cells [5–7]. In a 
concentration of 33.3 mM, glucose inhibited the cell viability compared with 5.5 mM glucose treated 
group (Figure 1A). However, 10 µM nifedipine suppressed this process significantly, which had no 
effect on 5.5 mM glucose cultured group (Figure 1A). In addition, nifedipine could not promote cell 
viability in normal glucose concentration (11.1 mM), but the value of its viability was approximately 
two times more than other groups (data not shown). 
The reduction of cell viability under high glucose-treatment could be involved in increased cell 
apoptotsis.  To  determine  the  apoptotic  rate  of  treated  INS-1  cells,  Hoechst  33342  staining  was 
performed. The cells incubated with 33.3 mM glucose showed less live cells and highly condensed 
chromatin in nuclei (Figure 1B). However, 10 µM nifedipine obviously decreased the apoptotic ratio in 
comparison  with  high  glucose  treated  cells  (Figure  1B).  Furthermore,  the  result  of  tunel  staining 
indicated  that  nifedipine  prevented  high  glucose-induced  INS-1  cell  apoptosis  (Figure  1C).  Taken 
together, it suggested that inhibition of calcium influx by L-type-Ca
2+-channel antagonist could provide 
benefit to prevent high glucose-induced β-cell apoptosis. Int. J. Mol. Sci. 2011, 12  7573 
 
Figure 1. (A) Nifedipine prevents high glucose-induced reduction of cell viability in INS-1 
cells. 5.5 mM glucose with (black bar) or without (white bar) nifedipine had no change in 
OD. 33.3 mM glucose (grey bar) significantly reduced the cell viability, 10 µM nifedipine 
reversed  this  effect;  (B)  Nifedipine  protected  INS-1  cells  from  high  glucose-induced 
apoptosis. Cells were divided into four groups as described above, Hoechst 33342 staining 
was  performed  to  calculate  the  apoptotic  rate,  data  was  repeated  at  least  three  times,  
scale bar = 50 µm, and referred to all panels; (C) Tunel staining of apoptotic cells. Apoptotic 
cells  were  marked  with  green  fluorescence,  the  nuclei  of  cells  are  stained  by  blue 
fluorescence, Data was repeated at least three times, scale bar = 50 µm, and referred to all 
panels. Data was shown as mean ± SE of three independent trails each performed with 
triplicate samples. The statistics graph shows * p < 0.05 compared to 33.3 mM glucose  
treated group. 
 
3.2. Nifedipine Prevents High Glucose-Induced β-Cell Death Through ER Stress Pathway 
Pancreatic  β-cell  generates  a  highly  developed  ER  for  Ca
2+  stores,  insulin  biosynthesis  and 
secretion [18,30,31].  Thus,  high  glucose-induced  β-cell  apoptosis  could  be  closely  related  to  the 
breakdown of Ca
2+ homeostasis, which was able to trigger ER stress [32]. To identify whether nifedipine 
protected INS-1 cells from high glucose-induced apoptosis via ER stress, the expression levels of some 
proteins involved in ER stress pathway were analyzed by western blot. As depicted in Figure 2, high 
glucose  caused an  elevated expression level of p-eIF2α, CHOP and caspase 3 proteins after 24 h Int. J. Mol. Sci. 2011, 12  7574 
 
treatment.  However,  these  enhanced  ER  stress  markers  were  reduced  by  nifedipine  (Figure  2), 
suggesting that L-type-Ca
2+-channel antagonists could suppress the high glucose-induced ER stress in 
INS-1 β-cells line. 
Figure 2. Western blot analysis of protein level of ER stress in INS-1 cells. Cells were 
divided into four groups as described above. After treatment, cell lysate was collected and 
subjected to western blot. Each blot was replicated at least three times. 
 
3.3. Nifedipine Improves the High Glucose-Impaired Calcium Homeostasis and GSIS in INS-1 Cells 
Chronic  hyperglycemia  is  thought  to  be  important  in  the  pathogenesis  of  T2D  [33,34].  Under 
physiological conditions, an increase in [Ca
2+]i in β-cells is of crucial importance in  coupling the 
GSIS [35,36]. Thus, the L-type-Ca
2+-channel antagonist, nifedipine, might inhibit the sustained increase 
in [Ca
2+]i. We had investigated the effect of nifedipine on the calcium influx in INS-1 β-cells. Nifedipine 
could dose-dependently inhibit calcium influx in INS-1 cells (Figure 3A). When cells were treated for 
6 h, high glucose promoted the activation of calcium influx and GSIS function (Figure 3B,D). However, 
in long-term incubation, the function of calcium influx was impaired by high glucose, which was 
protected by nifedipine (Figure 3B). Similarly, high glucose-impaired insulin content and GSIS in INS-1 
cells were also protected by nifedipine (Figure 3C,D). It seemed that intracellular calcium homeostasis 
played an important role in insulin secretion and synthesis. Insulin release in pancreatic β-cells was 
through the modulation of calcium influx, but the accumulation of excessive calcium would damage 
cells function, eventually leading to the β-cells apoptosis. Thus, nifedipine could partially prevent high 
glucose-induced INS-1 cell dysfunction through the regulation of adequate calcium levels. However, the 
abrogation  of  L-type-Ca
2+-channel  activation  did  not  completely  prevent  INS-1  cells  from  high 
glucose-induced  apoptosis,  suggesting  that  this  event  may  not  be  totally  dependent  on  
calcium homeostasis. Int. J. Mol. Sci. 2011, 12  7575 
 
Figure 3. (A) The effects of nifedipine and glucose on [Ca
2+]i level and glucose stimulated 
insulin secretion (GSIS). In acute [Ca
2+]i determination, nifedipine significant inhibited the 
calcium influx in 33.3 mM glucose stimulation dosedependently; (B) After 6 h treatment, 
33.3 mM glucose (dark grey bar) stimulated calcium influx, and 10 µM nifedipine (grey bar) 
partially prevented this effect. 24 h 33.3 mM glucose treatment impaired the calcium influx 
in INS-1 cells, but nifedipine partly inhibited this effect; (C) The insulin content of INS-1 
cells was marked with green fluorescence, 24 h incubation of 33.3 mM glucose obviously 
reduced the content of intracellular insulin in INS-1 cells. Scale bar = 25 µm, and refers to all 
panels; (D) GSIS in nifedipine and glucose incubated INS-1 cells. After 24 h treatment, 33.3 mM 
glucose (dark grey bar) impaired GSIS of INS-1 cells, and 10 µM nifedipine (grey bar) 
partially prevented this effect. * p < 0.05 compared to 33.3 mM glucose treated group. 
 
4. Discussion 
Sustained high glucose in vivo may disturb calcium metabolism in islet β-cells [37], which was a 
possible cause of hyperinsulinism in the development of diabetes mellitus. Calcium homeostasis is also 
important to the diversity of cellular processes including proliferation and apoptosis [38]. Nifedipine is a 
dihydropyridine calcium channel blocker, which has been used as antianginal and antihypertensive [39]. 
Recently,  it  has  been  reported  that  Nifedipine  prevented  induced  apoptosis  in  endothelial  cells  
and smooth muscle cells [40,41]. The L-type Ca
2+ channel has been reportedly expressed in INS-1 
β-cells [42,43], and β-cells were also thought to be sensitive to calcium channel blockers [44], and Int. J. Mol. Sci. 2011, 12  7576 
 
Jeffrey et al. demonstrated that blocking Ca
2+ influx with nifedipine could abolish the palmitate-induced 
ER stress [45]. Accordingly, in obesity or hyperglycemia associated T2D, the sustained elevation of 
[Ca
2+]i  is  able  to  generate  cell  death,  and  calcium  channel  antagonists  could  protect  β-cells  from 
palmitate-induced  apoptosis  [46].  However,  the  relationship  between  calcium  channel  and  high 
glucose-induced cell apoptosis has not been fully understood. 
Both free fatty acids (FFA)-amplified insulin secretion and the GSIS itself depend on calcium influx 
through calcium channels [47,48]. Thus, calcium influx could be a critical mediator not only in high 
FFA-induced β-cell dysfunction, but also in high glucose-induced impaired β-cells. 
In  addition,  previous  studies  had  shown  that  high  glucose-induced  apoptosis  occurred  through 
store-operated calcium entry and calcineurin in human umbilical vein endothelial cells and calcium 
channel blocker (diltiazem) inhibits apoptosis of vascular smooth muscle cell exposed to high glucose 
concentration  [49,50].  Our studies had verified that the calcium channel blocker, nifedipine, could 
reverse  high  glucose-induced  β-cell  dysfunction  and  apoptosis.  As  a  result  of  hyperglycemia  or 
hyperlipidemia in T2D, increased β-cell Ca
2+ flux could play a key role in the failure of β-cells. 
During the pre-diabetic state, pancreatic β-cells might trigger a compensatory phase [51,52]. In this 
phase, an elevated [Ca
2+]i could activate increased insulin output to adapt elevated glucose or FFA 
level [34,52].  However,  long-term  hyperinsulinemia  will  exhaust  β-cells,  and  various  Ca
2+  signals 
related to apoptosis are activated, such as PKR-like kinase (PERK) pathway [9,14]. In our results, PERK 
phosphorylated eukaryotic translation initiation factor2α led to inhibition of new protein translation [18]. 
In the process, a proapoptotic transcription factor, CHOP was up-regulated and activated death-related 
ER  stress  [20,53].  Finally,  caspase  3  was  activated  and  cytochrome  c  release  generated  
cell death. 
Nifedipine was reported to inhibit calcium influx [54] and suppressed glucose stimulated insulin 
secretion [42,54–56] in pancreatic β-cells and islets, but in the long term, exposure to high glucose, the 
dysfunction  of  calcium  influx  and  insulin  secretion  in  β-cells  occurs.  However,  Nifedipine  might 
prevent this compensation mechanism, which protects β-cells from glucose-induced dysfunction, and 
partially due to the regulation of insulin secretion and blocking of calcium-induced apoptotic signal. 
In conclusion, high glucose induces β-cell apoptosis which is highly dependent on calcium influx and 
calcium influx might be of crucial importance in the apoptosis process via ER stress pathway. Our 
results indicated that inhibition of calcium channel could benefit prevention of cell apoptosis, and 
suggest that the suppression of β-cell compensation might be beneficial in T2D. 
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